
The future of cancer care: Fast-tracking sustainability, access, and innovation in the Middle East
In the Middle East and North Africa, cancer is growing at an alarming …
Newsletters and Deep Dive digital magazine
In the Middle East and North Africa, cancer is growing at an alarming …
In an industry growing as quickly as cell therapy, keeping up with …
A trade organisation representing pharma manufacturers in Europe has …
At Frontiers Health 2023 , a panel will look at real-world, active …
MSD has been granted a priority review by the FDA for its pulmonary …
Imagine being told just after giving birth to a new baby that you …
Can you imagine a world where pharmaceutical marketing was as …
Biogen has decided to close down its digital health unit, formed just …
When prompted with the question, ’What is the world’s deadliest …
AstraZeneca’s Tagrisso could face some serious competition as a …
A court in Germany has suspended a trial discussing litigation …
Digital health and wellness company Virgin Pulse has said it plans to …
At Frontiers Health 2023, a panel will look a
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
To continue delivering high-quality and patient-centred care, the future oncology workforce of the NHS needs to be agile, expansive, and diverse.
It’s about that time of year when many global teams turn their attention towards annual strategic planning.
Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.
Life with a rare condition can have a significant impact – and often cause unmendable strain – on close relationships, from family members to friends to romantic partners.
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.